Memphasys Ltd

MEM

Company Profile

  • Business description

    Memphasys Ltd is an Australian reproductive biotechnology company developing and commercializing novel reproduction and fertility solutions for humans and animals. The products in its development pipeline include a range of devices, media, and in vitro diagnostic solutions. The company is currently focused on the commercialisation of its patented Felix System, a novel bio-separation technology for assisted reproduction, designed to revolutionise sperm separation in assisted reproductive technology (ART) by providing a rapid, gentle, and automated process. The group has only one operating segment, being Reproductive Technologies, the assets and liabilities of which are located in Australia.

  • Contact

    34-36 Richmond Road
    Level 1
    Homebush West
    SydneyNSW2140
    AUS

    T: +61 284157300

    https://www.memphasys.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 June 2026

    Employees

    28

Stocks News & Analysis

stocks

What Q4 US earnings did and didn’t tell us about AI and the outlook for tech shares

Tech saw solid earnings, but there are more questions around which companies will benefit from AI, and which will be hurt.
stocks

Top stocks of the year: Which opportunities remain in 2026?

A deep dive into the most traded stocks by Aussies in 2025 - and what this signals for the year ahead.
stocks

What did Morningstar subscribers buy and sell during February?

How the most traded shares stack up against our analysts views.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change

Market Movers